Is radiographic progression a downside of stopping TNF-inhibitor in RA patients with low disease activity, if this is followed by flare? A sub-study of the POET-US trial

por Lamers-Karnebeek, Femke B G, Luime, Jolanda J, Jansen, Tim L, van Riel, Piet L C M, Jacobs, Johannes W G
Publicado 2020

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

por Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, van Schaeybroeck, Barbara, Klaasen, Ruth, van Onna, Marieke, Bernelot Moens, Hein J., Visser, Henk, Schilder, Annemarie M., Kok, Marc R., Landewé, Robert B. M., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Publicado 2019

Multi-biomarker disease activity score as a predictor of disease relapse in patients with rheumatoid arthritis stopping TNF inhibitor treatment

por Ghiti Moghadam, Marjan, Lamers-Karnebeek, Femke B. G., Vonkeman, Harald E., ten Klooster, Peter M., Tekstra, Janneke, Schilder, Annemarie M., Visser, Henk, Sasso, Eric H., Chernoff, David, Lems, Willem F., van Schaardenburg, Dirk-Jan, Landewe, Robert, Bernelot Moens, Hein J., Radstake, Timothy R. D. J., van Riel, Piet L. C. M., van de Laar, Mart A. F. J., Jansen, Tim L.
Publicado 2018